A diagnosis of CCM was clinically assessed in SJLIFE but self-reported in CCSS, which may have contributed to a higher prevalence of CCM and potentially attenuated the associations between genetic variants in TTN and BAG3 and CCM risk. This evidence concerns the gene BAG3 and cerebral cavernous malformation.